Terumo (OTCMKTS:TRUMY) Share Price Crosses Below Fifty Day Moving Average – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $13.68 and traded as low as $13.6250. Terumo shares last traded at $13.7255, with a volume of 94,402 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Terumo Stock Up 2.0%

The firm’s 50 day simple moving average is $13.68 and its 200 day simple moving average is $13.69. The company has a market cap of $20.25 billion, a price-to-earnings ratio of 22.50 and a beta of 0.67. The company has a quick ratio of 0.97, a current ratio of 1.59 and a debt-to-equity ratio of 0.06.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. Terumo had a return on equity of 9.17% and a net margin of 12.09%.The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.84 billion. Sell-side analysts anticipate that Terumo Corp. will post 0.7 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.